Alopecia is a distressing side-effect of cancer treatment. Taxanes (TX). an
thracyclines (ANR) and etoposide (ET) have been consistently associated wit
h significant alopecia. We studied an effective scalp cooling system, the P
enguin Cold Cap system(TM), for the prevention of chemotherapy-induced alop
ecia in 70 patients receiving chemotherapy, including one of the following
major alopecia-causing agents: Group A, TX-based regimes (without ANR); Gro
up B. TX + ANR: Group C, ANR-based regimes (without TX): Group D, ET-based
regimes. Protection from hair loss was achieved by maintaining scalp temper
atures below 15 degrees C before, during and after chemotherapy by frequent
changing of the caps. Assessment was carried out using a grading system Fr
om 0 to 4. Grades 0-2 were considered as satisfactory hair protection, whil
st Grades 3-4 were considered failures. 57 patients were evaluable for asse
ssment. An overall 81% protection was achieved. In groups C and D 11 of 12
patients (92%) had no alopecia, whilst 30 of 34 patients (88%) treated with
taxanes had adequate hair protection. In Group B, 4 of 11 patients (36%) h
ad adequate hair protection. The system was well tolerated and is a very ef
fective method for protection from hair loss caused by TX, ANR and ET. Our
results are comparable with and, in most cases, better than those reported
in other studies using various alopecia preventive methods. (C) 2000 Elsevi
er Science Ltd. All rights reserved.